Rhesus disease: the model for fetal therapy

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Perinatal Medicine

Background:

• Rhesus (RhD) incompatibility is a significant cause of hemolytic disease of the fetus and newborn.
• Previous management strategies have focused on preventing RhD alloimmunization and treating affected fetuses.
• The severity of RhD-affected pregnancies necessitates continuous evaluation of therapeutic approaches.

Purpose of the Study:

• To comprehensively review therapeutic interventions for rhesus-affected pregnancies over the last four decades.
• To assess the effectiveness of various management strategies in improving fetal outcomes.
• To identify advancements and persistent challenges in managing RhD incompatibility.

Main Methods:

• Literature review of studies published over the past 40 years.
• Analysis of therapeutic approaches including prevention, monitoring, and treatment modalities.
• Synthesis of data on the impact of interventions on intrauterine fetal death and disease severity.

Main Results:

• Multiple therapeutic strategies have been implemented and refined over time.
• Significant progress has been made in preventing and managing RhD-related complications.
• The review highlights the evolution of treatment protocols and their outcomes.

Conclusions:

• The management of rhesus-affected pregnancies has evolved considerably, leading to improved fetal survival rates.
• Continued research and application of evidence-based practices are crucial for further advancements.
• Optimal management requires a multidisciplinary approach to address the complexities of RhD incompatibility.